PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-1956

  1. 1,139 Posts.
    lightbulb Created with Sketch. 199
    @Gan_Gans i am in part replying to your post linking to the posting about the ARDS patent.

    @The Yankee i am posting your amazing post from MSB. I strongly believe MSB and PAR could be a match made in heaven and would be interested if you have come across PAR and have any thoughts. I hope you don’t me linking your post.

    I find it interesting the Dr Ravi Krishnan was involved in earlier research into stem cells https://www.technologynetworks.com/...tem-cells-regenerates-damaged-pancreas-209563

    the yankee’s post is below

    https://hotcopper.com.au/threads/mscs-as-a-prophylactic-vaccine.6219571/#post-55300208


    https://www.forbes.com/sites/willia...l-strategy-to-fight-covid-19/?sh=5a6833e65b6e


    Multiple pathways is the only way really where we are going to see recovery of these complex diseases where inflammation has disrupted these pathways in the first place"


    With vaccine efficacy waning and new variants mutating, there is no end in sight for COVID-19 and COVID-19 induced ARDS.

    my ramblings below

    I am looking forward to the ARDS research data to come out. Imagine if iPPS does show some efficacy in the treatment of ARDS (Covid).


    You have to wonder why they would register a patent if they did think it was effective.


    Could IPPS be part of that multi-modal approach to treating Covid and the lingering effects of Long Covid
    Last edited by Hrdwk: 15/08/21
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
31.0¢
Change
0.035(12.7%)
Mkt cap ! $108.4M
Open High Low Value Volume
27.5¢ 31.0¢ 27.5¢ $108.9K 371.2K

Buyers (Bids)

No. Vol. Price($)
1 1000 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 17420 5
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.